Early versus deferred standard androgen suppression therapy for advanced hormone‐sensitive prostate cancer

BACKGROUND: Standard androgen suppression therapy (AST) using surgical or medical castration is considered a mainstay of advanced hormone‐sensitive prostate cancer treatment. AST can be initiated early when disease is asymptomatic or deferred when patients suffer symptoms of disseminated prostate ca...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cochrane Database Syst Rev
Главные авторы: Kunath, Frank, Jensen, Katrin, Pinart, Mariona, Kahlmeyer, Andreas, Schmidt, Stefanie, Price, Carrie L, Lieb, Verena, Dahm, Philipp
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons, Ltd 2019
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6564091/
https://ncbi.nlm.nih.gov/pubmed/31194882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003506.pub2
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы